Cargando…

Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria

Background: Nitisinone-induced hypertyrosinaemia is well documented in Alkaptonuria (AKU), and there is uncertainty over whether it may contribute to a decline in cognitive function and/or mood by altering neurotransmitter metabolism. The aim of this work was to evaluate the impact of nitisinone on...

Descripción completa

Detalles Bibliográficos
Autores principales: Davison, Andrew S., Norman, Brendan P., Sutherland, Hazel, Milan, Anna M., Gallagher, James A., Jarvis, Jonathan C., Ranganath, Lakshminarayan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230570/
https://www.ncbi.nlm.nih.gov/pubmed/35736410
http://dx.doi.org/10.3390/metabo12060477
_version_ 1784735093342863360
author Davison, Andrew S.
Norman, Brendan P.
Sutherland, Hazel
Milan, Anna M.
Gallagher, James A.
Jarvis, Jonathan C.
Ranganath, Lakshminarayan R.
author_facet Davison, Andrew S.
Norman, Brendan P.
Sutherland, Hazel
Milan, Anna M.
Gallagher, James A.
Jarvis, Jonathan C.
Ranganath, Lakshminarayan R.
author_sort Davison, Andrew S.
collection PubMed
description Background: Nitisinone-induced hypertyrosinaemia is well documented in Alkaptonuria (AKU), and there is uncertainty over whether it may contribute to a decline in cognitive function and/or mood by altering neurotransmitter metabolism. The aim of this work was to evaluate the impact of nitisinone on the cerebrospinal fluid (CSF) metabolome in a murine model of AKU, with a view to providing additional insight into metabolic changes that occur following treatment with nitisinone. Methods: 17 CSF samples were collected from BALB/c Hgd(−/−) mice (n = 8, treated with nitisinone—4 mg/L and n = 9, no treatment). Samples were diluted 1:1 with deionised water and analysed using a 1290 Infinity II liquid chromatography system coupled to a 6550 quadrupole time-of-flight mass spectrometry (Agilent, Cheadle, UK). Raw data were processed using a targeted feature extraction algorithm and an established in-house accurate mass retention time database. Matched entities (±10 ppm theoretical accurate mass and ±0.3 min retention time window) were filtered based on their frequency and variability. Experimental groups were compared using a moderated t-test with Benjamini–Hochberg false-discovery rate adjustment. Results: L-Tyrosine, N-acetyl-L-tyrosine, γ-glutamyl-L-tyrosine, p-hydroxyphenylacetic acid, and 3-(4-hydroxyphenyl)lactic acid were shown to increase in abundance (log2 fold change 2.6–6.9, 3/5 were significant p < 0.05) in the mice that received nitisinone. Several other metabolites of interest were matched, but no significant differences were observed, including the aromatic amino acids phenylalanine and tryptophan, and monoamine metabolites adrenaline, 3-methoxy-4-hydroxyphenylglycol, and octopamine. Conclusions: Evaluation of the CSF metabolome of a murine model of AKU revealed a significant increase in the abundance of a limited number of metabolites following treatment with nitisinone. Further work is required to understand the significance of these findings and the mechanisms by which the altered metabolite abundances occur.
format Online
Article
Text
id pubmed-9230570
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92305702022-06-25 Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria Davison, Andrew S. Norman, Brendan P. Sutherland, Hazel Milan, Anna M. Gallagher, James A. Jarvis, Jonathan C. Ranganath, Lakshminarayan R. Metabolites Article Background: Nitisinone-induced hypertyrosinaemia is well documented in Alkaptonuria (AKU), and there is uncertainty over whether it may contribute to a decline in cognitive function and/or mood by altering neurotransmitter metabolism. The aim of this work was to evaluate the impact of nitisinone on the cerebrospinal fluid (CSF) metabolome in a murine model of AKU, with a view to providing additional insight into metabolic changes that occur following treatment with nitisinone. Methods: 17 CSF samples were collected from BALB/c Hgd(−/−) mice (n = 8, treated with nitisinone—4 mg/L and n = 9, no treatment). Samples were diluted 1:1 with deionised water and analysed using a 1290 Infinity II liquid chromatography system coupled to a 6550 quadrupole time-of-flight mass spectrometry (Agilent, Cheadle, UK). Raw data were processed using a targeted feature extraction algorithm and an established in-house accurate mass retention time database. Matched entities (±10 ppm theoretical accurate mass and ±0.3 min retention time window) were filtered based on their frequency and variability. Experimental groups were compared using a moderated t-test with Benjamini–Hochberg false-discovery rate adjustment. Results: L-Tyrosine, N-acetyl-L-tyrosine, γ-glutamyl-L-tyrosine, p-hydroxyphenylacetic acid, and 3-(4-hydroxyphenyl)lactic acid were shown to increase in abundance (log2 fold change 2.6–6.9, 3/5 were significant p < 0.05) in the mice that received nitisinone. Several other metabolites of interest were matched, but no significant differences were observed, including the aromatic amino acids phenylalanine and tryptophan, and monoamine metabolites adrenaline, 3-methoxy-4-hydroxyphenylglycol, and octopamine. Conclusions: Evaluation of the CSF metabolome of a murine model of AKU revealed a significant increase in the abundance of a limited number of metabolites following treatment with nitisinone. Further work is required to understand the significance of these findings and the mechanisms by which the altered metabolite abundances occur. MDPI 2022-05-25 /pmc/articles/PMC9230570/ /pubmed/35736410 http://dx.doi.org/10.3390/metabo12060477 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Davison, Andrew S.
Norman, Brendan P.
Sutherland, Hazel
Milan, Anna M.
Gallagher, James A.
Jarvis, Jonathan C.
Ranganath, Lakshminarayan R.
Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria
title Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria
title_full Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria
title_fullStr Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria
title_full_unstemmed Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria
title_short Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria
title_sort impact of nitisinone on the cerebrospinal fluid metabolome of a murine model of alkaptonuria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230570/
https://www.ncbi.nlm.nih.gov/pubmed/35736410
http://dx.doi.org/10.3390/metabo12060477
work_keys_str_mv AT davisonandrews impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria
AT normanbrendanp impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria
AT sutherlandhazel impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria
AT milanannam impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria
AT gallagherjamesa impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria
AT jarvisjonathanc impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria
AT ranganathlakshminarayanr impactofnitisinoneonthecerebrospinalfluidmetabolomeofamurinemodelofalkaptonuria